On January 3, the Food and Drug Administration (FDA) quietly made long-awaited changes to the regulations surrounding mifepristone, one of two drugs used in medication abortion. Though the agency merely updated its website without even issuing a press release, the news was met with fanfare: “Abortion Pills Can Now Be Offered at Retail Pharmacies, F.D.A. Says”; “Abortion Pill Could Soon Become Much…
